Agilent Technologies (NYSE:A) updated its FY 2022 earnings guidance on Monday. The company provided earnings per share guidance of $4.760-$4.860 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.240. The company issued revenue guidance of $6.65 billion-$6.73 billion, compared to the consensus revenue estimate of $6.01 billion.Agilent Technologies also updated its FY22 guidance to $4.76-4.86 EPS.
Several research analysts have recently issued reports on the stock. Cowen increased their price objective on shares of Agilent Technologies from $180.00 to $187.00 and gave the company an outperform rating in a report on Tuesday. SVB Leerink increased their price objective on shares of Agilent Technologies from $170.00 to $175.00 and gave the company an outperform rating in a report on Tuesday. Stifel Nicolaus increased their price objective on shares of Agilent Technologies from $162.00 to $169.00 and gave the company a hold rating in a report on Tuesday. Citigroup raised their target price on shares of Agilent Technologies from $160.00 to $190.00 and gave the stock a buy rating in a report on Wednesday, August 18th. Finally, Bank of America raised their target price on shares of Agilent Technologies from $177.00 to $179.00 and gave the stock a buy rating in a report on Tuesday. One research analyst has rated the stock with a hold rating and eighteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of Buy and an average target price of $151.75.
Shares of NYSE:A traded down $1.81 during mid-day trading on Thursday, hitting $152.97. The stock had a trading volume of 2,291,394 shares, compared to its average volume of 1,621,541. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.63 and a current ratio of 2.11. The company has a market cap of $46.31 billion, a PE ratio of 47.80, a P/E/G ratio of 2.67 and a beta of 0.98. Agilent Technologies has a 12-month low of $112.47 and a 12-month high of $179.57. The company’s 50 day moving average is $159.22 and its 200-day moving average is $154.31.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 26th. Shareholders of record on Tuesday, January 4th will be given a $0.21 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Monday, January 3rd. This represents a $0.84 dividend on an annualized basis and a yield of 0.55%. Agilent Technologies’s dividend payout ratio is presently 24.38%.
In other Agilent Technologies news, SVP Padraig Mcdonnell sold 1,500 shares of the stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $165.00, for a total value of $247,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
An institutional investor recently raised its position in Agilent Technologies stock. Morgan Stanley grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 2.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,154,775 shares of the medical research company’s stock after purchasing an additional 33,059 shares during the quarter. Morgan Stanley owned about 0.38% of Agilent Technologies worth $170,688,000 as of its most recent filing with the Securities and Exchange Commission.
Agilent Technologies Company Profile
Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.
Read More: Price to Earnings Ratio (PE)
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.